United States
Germany
Japan
United Kingdom
China
CNY 6,881.00
6周
Recombinant Anti-CD11b (Clone 5C6 (recombinant version))
| Applications | IF, IHC |
| Reactivities | Mouse, Human |
Antibodies
Recombinant Anti-CD3 epsilon (Clone UCHT1)
| Applications | FC, IHC |
| Reactivities | Human |
Recombinant Anti-CD28 (Clone 15E8)
| Applications | ELISA, FC |
| Reactivities | Human |
Recombinant Anti-CD38 (Clone OKT10)
| Applications | FC, IP |
| Reactivities | Human |
Recombinant Anti-CD64 (Clone H22)
| Applications | CT, FC |
| Reactivities | Human |
Recombinant Anti-tau (Clone Tau-5)
| Applications | EM, IF |
| Reactivities | Human, Mouse, Rat, Sheep |
Recombinant Anti-alpha-4 integrin (Clone 21.6)
| Applications | Bl, ELISA |
| Reactivities | Human |
Recombinant Anti-Fc epsilon R (Clone IB10)
| Applications | Bl, IF |
| Reactivities | Human |
Recombinant Anti-MS4A4A (Clone 3F2)
| Applications | FC, IP |
| Reactivities | Human |
Recombinant Anti-CD154 (Clone YMF323.6)
| Applications | FC, WB |
| Reactivities | Human |
Recombinant Anti-GM2 ganglioside (Clone L55-81)
| Applications | ELISA, IHC |
| Reactivities | Human |
Recombinant Anti-Glycophorin A M antigen (Clone M2A1)
| Applications | ELISA, Inhib |
| Reactivities | Human |
Recombinant Anti-EDAR (Clone EDAR12)
| Applications | ELISA, WB |
| Reactivities | Human, Mouse, Rat, Dog, Chicken |
Anti-Calponin protein [24H5], Rabbit IgG, kappa
| Applications | IHC, WB |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format for improved compatibility with existing reagents assays and techniques. |
Anti-Beta Dystroglycan [P38G1], Rabbit IgG, kappa
| Applications | ELISA, FC |
| Reactivities | Human, Mouse |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. |
活动过滤器
优化搜索结果
Category
Target Symbol
- CD40LG (6)
- EGFR (6)
- CD4 (5)
- CCR5 (4)
- CD19 (4)
- CD37 (4)
- CD3E (4)
- CD52 (4)
- IL2RA (4)
- MSLN (4)
- CD38 (3)
- CD40 (3)
- CD44 (3)
- ERBB2 (3)
- HSPB1 (3)
- INSR (3)
- ITGA2B (3)
- MUC1 (3)
- TNF (3)
- ADRB2 (2)
- AOC3 (2)
- C5AR1 (2)
- CD27 (2)
- CD28 (2)
- CD33 (2)
- CD53 (2)
- CD63 (2)
- CD74 (2)
- CD81 (2)
- CEA (2)
- CR1 (2)
- EPCAM (2)
- FCER1G (2)
- FN1 (2)
- GPC3 (2)
- IL18 (2)
- ITGA4 (2)
- ITGAL (2)
- ITGB2 (2)
- ITGB7 (2)
- MME (2)
- NOTCH2 (2)
- PRDX2 (2)
- PRDX4 (2)
- PXN (2)
- RAD23B (2)
- TAG72 (2)
- TNFRSF8 (2)
- VEGFA (2)
- XPNPEP1 (2)
- ABCB1 (1)
- ACKR1 (1)
- ACTA1 (1)
- AFP (1)
- AGER (1)
- ALPHA SMOOTH MUSCLE ACTIN (1)
- ANO1 (1)
- ANXA1 (1)
- ANXA4 (1)
- APP (1)
- B2M (1)
- BAX (1)
- BRD4 (1)
- BSG (1)
- C3AR1 (1)
- CALR (1)
- CBX1 (1)
- CBX2 (1)
- CBX5 (1)
- CCR3 (1)
- CCR4 (1)
- CD15 (1)
- CD16 (1)
- CD1A (1)
- CD2 (1)
- CD200R1 (1)
- CD22 (1)
- CD274 (1)
- CD34 (1)
- CD47 (1)
- CD5 (1)
- CD59 (1)
- CD7 (1)
- CD8 (1)
- CD8A (1)
- CDH1 (1)
- CDH17 (1)
- CDX2 (1)
- CEACAM5 (1)
- CENPE (1)
- CHRNB2 (1)
- CLEC4A (1)
- CLEC4M (1)
- CLU (1)
- CNN2 (1)
- CSF2RB (1)
- CXCL8 (1)
- CXCR1 (1)
- CXCR2 (1)
- DDR1 (1)
Applications
Antibody Hosts
Conjugates
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. (21)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format for improved compatibility with existing reagents assays and techniques. (9)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format for improved compatibility with existing reagents assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format for improved compatibility with existing reagents assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format for improved compatibility with existing reagents assays and techniques. (1)
